5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic Review (Q31012120)

28 June 2017

title

5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic Review (English)

1 reference

28 June 2017

1 reference

Jacques Guyotat

1

1 reference

28 June 2017

Johan Pallud

2

1 reference

28 June 2017

Xavier Armoiry

3

1 reference

28 June 2017

Vladislav Pavlov

4

1 reference

28 June 2017

Philippe Metellus

5

1 reference

28 June 2017

publication date

1 January 2016

1 reference

Advances and Technical Standards in Neurosurgery

28 June 2017

number of pages

30

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 June 2017

issue

43

1 reference

28 June 2017

page(s)

61-90

1 reference

Is fluorescein-guided technique able to help in resection of high-grade gliomas?

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

¹¹C-methionine uptake and intraoperative 5-aminolevulinic acid-induced fluorescence as separate index markers of cell density in glioma: a stereotactic image-histological analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Fluorescence-guided malignant glioma resections

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

An In Vitro Comparison of the Effects of the Iron‐Chelating Agents, CP94 and Dexrazoxane, on Protoporphyrin IX Accumulation for Photodynamic Therapy and/or Fluorescence Guided Resection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: theoretical, biochemical and practical aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Transport of 5-aminolevulinic acid between blood and brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Reliability of tumor volume estimation from MR images in patients with malignant glioma. Results from the American College of Radiology Imaging Network (ACRIN) 6662 Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Improving the extent of malignant glioma resection by dual intraoperative visualization approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Hypoxia significantly reduces aminolaevulinic acid-induced protoporphyrin IX synthesis in EMT6 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Enhanced optical imaging of human gliomas and tumor margins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The value of glioma extent of resection in the modern neurosurgical era.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Fluorescence localization in tumour and normal brain after intratumoral injection of haematoporphyrin derivative into rat brain tumour

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

MGMT gene silencing and benefit from temozolomide in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

[Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients].

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

5‐Aminolevulinic Acid‐induced Protoporphyrin IX Levels in Tissue of Human Malignant Brain Tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Quantitative Imaging Study of Extent of Surgical Resection and Prognosis of Malignant Astrocytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

ALA and its clinical impact, from bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The use of intraoperative MRI for the treatment of glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Fluorescence imaging and spectroscopy of 5-aminolevulinic acid induced protoporphyrin IX for the detection of neoplastic lesions in the oral cavity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Tissue uptake of o-aminolaevulinic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Two-peaked 5-ALA-induced PpIX fluorescence emission spectrum distinguishes glioblastomas from low grade gliomas and infiltrative component of glioblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Improved surgical resection of human brain tumors: Part I. A preliminary study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The invasive nature of glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Guidelines for the treatment of newly diagnosed glioblastoma: introduction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Fluorescence-guided surgery for glioblastoma multiforme using high-dose fluorescein sodium with excitation and barrier filters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Fluorescence and image guided resection in high grade glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Role of intraoperative neurophysiological monitoring during fluorescence-guided resection surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Review of Neurosurgical Fluorescence Imaging Methodologies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Hypericin for visualization of high grade gliomas: first clinical experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid).

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Comparison of navigated 3D ultrasound findings with histopathology in subsequent phases of glioblastoma resection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The impact of enrollment in clinical trials on survival of patients with glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Glioma extent of resection and its impact on patient outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

An extent of resection threshold for newly diagnosed glioblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Pharmacokinetics of 5-aminolevulinic-acid-induced porphyrins in tumour-bearing mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The silent loss of neuronavigation accuracy: a systematic retrospective analysis of factors influencing the mismatch of frameless stereotactic systems in cranial neurosurgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Kinetics of Photofrin II in perifocal brain edema.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Intraoperative Detection of Malignant Gliomas by 5-Aminolevulinic Acid-induced Porphyrin Fluorescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Enhanced expression of coproporphyrinogen oxidase in malignant brain tumors: CPOX expression and 5-ALA-induced fluorescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

An autoradiographic study of delta-aminolevulinic acid uptake by mouse brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Impact of the Combination of 5-Aminolevulinic Acid–Induced Fluorescence with Intraoperative Magnetic Resonance Imaging–Guided Surgery for Glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Ability of navigated 3D ultrasound to delineate gliomas and metastases--comparison of image interpretations with histopathology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low- and high-grade glioma surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Side effects and photosensitization of human tissues after aminolevulinic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Neuronavigation and surgery of intracerebral tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-21359-0_3

10.1007/978-3-319-21359-0_3

31 March 2020

Identifiers

DOI

1 reference

28 June 2017

1 reference